JP Morgan Chase
AONC

JP Morgan Chase’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

JP Morgan Chase’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$12 – 8015
2023
Q4 		$12 Sell
2
-321
-99% -$2.08K ﹤0.01% 7411
2023
Q3 		$3K Buy
+323
New +$3.97K ﹤0.01% 6467

Other funds holding AONC

AC
Applied Capital Little Rock, Arkansas $310M AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BW
BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFFP
Center for Financial Planning Southfied, Michigan $1.07B AUM 18.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase's AONC Position: Q1 2024 in Review

JP Morgan Chase sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2024, closing a stake of 2 shares — an estimated $12 sold.

JP Morgan Chase first reported a position in AONC in Q3 2023 and held it in 2 quarters. The position peaked at $3K in Q3 2023. 10 funds tracked by Wall St. Rank hold AONC as of Q1 2024.

  • JP Morgan Chase reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 2 American Oncology Network, Inc. Class A Common Stock shares in Q1 2024, an estimated $12.
  • JP Morgan Chase first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2023 and held it in 2 quarters.
  • JP Morgan Chase's American Oncology Network, Inc. Class A Common Stock position peaked at $3K in Q3 2023.
  • 10 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.